New Key Statistics Module, Z-Score and F-Score
HKSE:02289 Key Ratios
Market Cap HK$ M | 873.72 |
Enterprise Value HK$ M | 2,242.69 |
P/E(ttm) | 15.54 |
PE Ratio without NRI | 15.69 |
Forward PE Ratio | -- |
Price/Book | 1.37 |
Price/Sales | 0.18 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.63 |
Revenue (TTM) HK$ M | 4,861.00 |
EPS (TTM) HK$ | 0.52 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 7.00 |
y-y EBITDA Growth Rate % | -19.90 |
EV-to-EBIT | 16.15 |
EV-to-EBITDA | 12.93 |
PEG | 2.24 |
Shares Outstanding M | 108.00 |
Net Margin (%) | 1.16 |
Operating Margin % | 3.03 |
Pre-tax Margin (%) | 1.59 |
Quick Ratio | 0.77 |
Current Ratio | 1.07 |
ROA % (ttm) | 1.66 |
ROE % (ttm) | 8.78 |
ROIC % (ttm) | 5.06 |
Dividend Yield % | 4.08 |
Altman Z-Score | 1.80 |
HKSE:02289 Number of Guru Trades
HKSE:02289 Volume of Guru Trades
Gurus Latest Trades with HKSE:02289
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02289 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Charmacy Pharmaceutical Co Ltd Insider Transactions
No Available Data